sibutramine has been researched along with dexfenfluramine in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (22.22) | 18.2507 |
| 2000's | 10 (55.56) | 29.6817 |
| 2010's | 4 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Drouin, P; Hanotin, C; Jones, SP; Leutenegger, E; Thomas, F | 1 |
| Rissanen, A | 1 |
| De Leeuw, IH; Van Gaal, LF; Wauters, MA | 1 |
| Kalia, M; Kramer, M; Miller, DB; O'Callaghan, JP | 1 |
| Aronne, LJ; Hirsch, J; Mackintosh, RM | 1 |
| Cheetham, SC; Heal, DJ; Slater, NA; Viggers, JA | 1 |
| Ballmer, PE; Imoberdorf, R | 1 |
| Ryan, DH | 1 |
| Czupryniak, L; Drzewoski, J | 1 |
| Bénardeau, A; Künnecke, B; Verry, P; von Kienlin, M | 1 |
| Alemany, M; Cabot, C; Fernández-López, JA; Ferrer-Lorente, R; Remesar, X | 1 |
| Foltin, RW | 1 |
| Brune, ME; Bush, EN; Droz, BA; Fey, T; Jacobson, PB; Knourek-Segel, VE; Lin, E; Shapiro, R | 1 |
| Bedros, JR; Medvegy, M; Pados, G; Simonyi, G | 1 |
| Arumugam, S; Devan, SRK; Poosala, S; Shankar, G | 1 |
5 review(s) available for sibutramine and dexfenfluramine
| Article | Year |
|---|---|
Pharmacological intervention: the antiobesity approach.
Topics: Appetite Depressants; Blood Glucose; Controlled Clinical Trials as Topic; Cyclobutanes; Dexfenfluramine; Diabetes Mellitus, Type 2; Humans; Lactones; Longitudinal Studies; Obesity; Orlistat; Weight Loss | 1998 |
Anti-obesity drugs: what does sibutramine offer? An analysis of its potential contribution to obesity treatment.
Topics: Adipose Tissue; Appetite Depressants; Blood Glucose; Blood Pressure; Cyclobutanes; Dexfenfluramine; Dose-Response Relationship, Drug; Energy Intake; Energy Metabolism; Humans; Lipids; Obesity; Weight Loss | 1998 |
[Obesity: principles of drug therapy].
Topics: Aminorex; Anti-Obesity Agents; Appetite Depressants; Chronic Disease; Combined Modality Therapy; Cyclobutanes; Dexfenfluramine; Diet, Reducing; Drug and Narcotic Control; Germany; Heart Valve Diseases; Humans; Hypertension, Pulmonary; Lactones; Obesity; Orlistat; Phentermine | 2000 |
Use of sibutramine and other noradrenergic and serotonergic drugs in the management of obesity.
Topics: Adrenergic Agents; Appetite Depressants; Cyclobutanes; Dexfenfluramine; Dextroamphetamine; Fenfluramine; Heart Valve Diseases; Humans; Obesity; Phenylpropanolamine; Serotonin Agents; Weight Loss | 2000 |
[The pharmacological treatment of obesity: past, present and future].
Topics: Amides; Anti-Obesity Agents; Anticonvulsants; Antidepressive Agents; Basal Metabolism; Benzazepines; Benzoxazines; Body Mass Index; Bridged Bicyclo Compounds, Heterocyclic; Ciliary Neurotrophic Factor; Clinical Trials as Topic; Combined Modality Therapy; Cyclobutanes; Dexfenfluramine; Fatty Acids; Female; Fenfluramine; Glucagon-Like Peptide 1; Human Growth Hormone; Humans; Intestinal Absorption; Lactones; Leptin; Life Style; Liraglutide; Male; Norepinephrine; Obesity; Obesity, Morbid; Orlistat; Piperidines; Pyrazoles; Pyridines; Receptor, Melanocortin, Type 4; Rimonabant; Satiation; Serotonin; Sodium-Glucose Transport Proteins; Sucrose; Thyroid Hormones | 2012 |
2 trial(s) available for sibutramine and dexfenfluramine
| Article | Year |
|---|---|
A comparison of sibutramine and dexfenfluramine in the treatment of obesity.
Topics: Adult; Appetite Depressants; Body Constitution; Body Mass Index; Body Weight; Cyclobutanes; Dexfenfluramine; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Obesity; Serotonin Receptor Agonists; Treatment Outcome | 1998 |
The effects of drugs used to treat obesity on the autonomic nervous system.
Topics: Adrenergic beta-Antagonists; Adult; Appetite Depressants; Atropine; Autonomic Nervous System; Basal Metabolism; Calorimetry; Creatinine; Cyclobutanes; Dexfenfluramine; Dopamine; Epinephrine; Heart Rate; Humans; Male; Norepinephrine; Obesity; Parasympatholytics; Phentermine; Propanolamines; Serotonin Receptor Agonists; Single-Blind Method | 2000 |
11 other study(ies) available for sibutramine and dexfenfluramine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Studies confirm link between fen-phen and heart-valve disease.
Topics: Appetite Depressants; Cyclobutanes; Dexfenfluramine; Drug Combinations; Fenfluramine; Heart Valve Diseases; Humans; Obesity; Phentermine | 1998 |
Comparative study of fluoxetine, sibutramine, sertraline and dexfenfluramine on the morphology of serotonergic nerve terminals using serotonin immunohistochemistry.
Topics: Animals; Appetite Depressants; Body Weight; Cyclobutanes; Dexfenfluramine; Eating; Fluoxetine; Immunohistochemistry; Male; N-Methyl-3,4-methylenedioxyamphetamine; Prefrontal Cortex; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Serotonin Receptor Agonists; Sertraline | 2000 |
Sibutramine does not decrease the number of 5-HT re-uptake sites in rat brain and, like fluoxetine, protects against the deficits produced by dexfenfluramine.
Topics: Animals; Appetite Depressants; Brain; Cyclobutanes; Dexfenfluramine; Fluoxetine; Male; Paroxetine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists | 2000 |
[The role of pharmacotherapy for treatment of obesity in adults].
Topics: Adult; Animals; Anti-Obesity Agents; Chlorphentermine; Cyclobutanes; Dexfenfluramine; Dopamine Agonists; Ephedrine; Fluoxetine; Humans; Lactones; Mazindol; Obesity; Orlistat | 2000 |
Quantitative body composition analysis in awake mice and rats by magnetic resonance relaxometry.
Topics: Animals; Anti-Obesity Agents; Body Composition; Calibration; Cross-Sectional Studies; Cyclobutanes; Dexfenfluramine; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred AKR; Mice, Inbred C57BL; Mice, Obese; Obesity; Rats; Rats, Sprague-Dawley; Rats, Wistar; Rats, Zucker; Reproducibility of Results; Sensitivity and Specificity; Weight Loss | 2004 |
Effects of oleoyl-estrone with dexfenfluramine, sibutramine or phentermine on overweight rats.
Topics: Animals; Anti-Obesity Agents; Body Weight; Cyclobutanes; Dexfenfluramine; Drug Interactions; Drug Therapy, Combination; Energy Metabolism; Estrone; Insulin; Lipids; Male; Obesity; Oleic Acids; Phentermine; Rats; Rats, Wistar | 2005 |
Effects of sibutramine on the appetitive and consummatory aspects of feeding in non-human primates.
Topics: Animals; Appetite Depressants; Conditioning, Operant; Consummatory Behavior; Cyclobutanes; Data Interpretation, Statistical; Dexfenfluramine; Dose-Response Relationship, Drug; Eating; Food; Male; Papio; Reinforcement Schedule; Sex Characteristics | 2006 |
Chronic treatment with either dexfenfluramine or sibutramine in diet-switched diet-induced obese mice.
Topics: Animals; Anti-Obesity Agents; Body Weight; Cyclobutanes; Dexfenfluramine; Diet, Fat-Restricted; Ghrelin; Growth Hormone; Male; Mice; Obesity; Peptide Hormones; Thinness; Weight Gain | 2006 |
Differential sensitivity of chronic high-fat-diet-induced obesity in Sprague-Dawley rats.
Topics: Animals; Cyclobutanes; Dexfenfluramine; Diet, High-Fat; Eating; Male; Obesity; Oxygen Consumption; Rats; Rats, Sprague-Dawley | 2018 |